Swiss

Index
Globenewswire

Sandoz Announces Changes in the Board of Directors

Globenewswire

Sandoz Launches First and Only Biosimilar for Multiple Sclerosis, Tyruko® (Natalizumab), in Germany

Globenewswire

Elevating MSP Excellence: Acronis MSP Academy Grows with 19 New Modules and a Video Library of 100+ Strategic Insights

Globenewswire

Sportradar Announces Additional Strategic Actions to Streamline Organizational Structure and Drive Growth and Innovation

Globenewswire

Acronis Redefines Cybersecurity Landscape with Native Integration of Advanced Security and EDR Technologies

Globenewswire

Sportradar Launches FanID Connecting Rightsholders and Brands with Sports Fans in a Post-Cookie World

Globenewswire

First Ever Global Campaign to Improve Access to Assistive Technology Launched at World Economic Forum

Globenewswire

Essential Pharma Acquires European Rights to Colobreathe®(Colistimethate Codium) from Teva

Media OutReach

Modex Takes Strategic Management of FIFA+ Collect

Globenewswire

Tangem Sets New Standards for Crypto Hardware Wallet Integrity: Introducing Firmware Attestation, Audited by Riscure

Globenewswire

Sandoz Launches Hyrimoz® (adalimumab) High-concentration Formulation in Europe, Aiming to Improve Patient Care

Media OutReach

pCloud, the Leading Cloud Storage Service, Unveils the Exclusive Lifetime 3in1 Plan for Singles Day Only

Globenewswire

Acronis Helps Managed Service Providers Grow by Introducing MSP Academy

Globenewswire

MoonLake Immunotherapeutics Announces Landmark Phase 2 Results for Nanobody® Sonelokimab in Active Psoriatic Arthritis

Media OutReach

Global Leaders Agree to Full Phase-Out of Fluorescent Lighting

Globenewswire

Hitachi Energy Passes 150 GW in HVDC Links Integrated into the Power System, Expands Capacity to Meet Accelerating Energy Transition Demand

Globenewswire

Hitachi Energy Acquires Eks Energy

Globenewswire

QuantalRF Novel RF Architecture Radically Improves Power Efficiency of Wi-Fi 7 Front-Ends

Globenewswire

MoonLake Immunotherapeutics Announces the full Dataset from its 24-week MIRA Clinical Trial, Establishing the Nanobody® Sonelokimab as a Highly Promising and Differentiated Therapeutic Solution for Hidradenitis Suppurativa

Globenewswire

Acronis EDR Named “Endpoint Security Innovation of the Year” in 7th Annual CyberSecurity Breakthrough Awards Program

Globenewswire

Sandoz Enters New Era as Standalone Global Leader and European Champion in Generic and Biosimilar Medicines

Media OutReach

Netcetera AG: Tokenization Benefits Now Available to GPE Merchants in Europe

Globenewswire

Acino Significantly Expands Presence and Capabilities in Latin America Through Acquisition of M8 Pharmaceuticals

Globenewswire

Acronis Unveils First Ever AI-powered Cyber Protection Software for Consumers

Globenewswire

Acronis Introduces Advanced Automation to Simplify MSP Business Operations for Enhanced Productivity